Feeds
333029 items (307320 unread) in 109 feeds
- Dictionary.com Word of the Day (577 unread)
- Yahoo! News: Most Viewed (15658 unread)
The Economic Times - Healthcare / Biotech (10 unread)
-
Standing guard: NPPA asked to monitor prices of antibiotics
Posted: March 5th, 2010, 2:28pm EST
Tags: [edit]
The department of pharmaceuticals, or DoP, has asked the country’s drug price regulator to be on guard against a possible spike in antibiotic prices after a proposed anti-dumping duty on import of key ingredients takes effect. -
Strides to acquire Aspen's Brazilian facility for $75 mn
Posted: March 4th, 2010, 1:14am EST
Tags: [edit]
Pharma firm Strides Arcolab today said it has entered into an agreement with South Africa-based Aspen to acquire the latters facility in Brazil for $75 million (nearly Rs 343 crore). -
Wockhardt's asset sale caught in creditors’ crossfire
Posted: March 3rd, 2010, 2:30pm EST
Tags: [edit]
The sale of Wockhardt’s nutrition business to Abbott Laboratories has hit a roadblock as differences regarding rights on the sale proceeds have cropped up between the company’s secured and unsecured creditors. -
Zydus applies for Phase II & III H1N1 vaccine trials
Posted: March 3rd, 2010, 8:06am EST
Tags: [edit]
The race amongst Indian swine flu vaccine-makers seems to be moving to the next level with Cadila Healthcare Ltd, the Rs 2,900-crore Zydus Group's listed entity, filing for the next phase of clinical trials after completing the first phase. -
Ranbaxy loses out on FDA delay
Posted: March 2nd, 2010, 5:26pm EST
Tags: [edit]
Ranbaxy, the Indian unit of Japanese drugmaker Daiichi Sankyo, was to launch the generic version of the Japan-based Astellas’ Flomax on March 2 in the US, eight weeks before the drug’s patent expires in the US following an out-of-court settlement in 2007. -
Glenmark unit gets US nod for Parkinson's drug
Posted: March 2nd, 2010, 3:21am EST
Tags: [edit]
Glenmark Pharmaceuticals said its unit, Glenmark Generics Ltd, secured the US Food and Drug Administration approval to sell ropinirole hydrochloride tabltes in the United States. -
SC rejects Bayer’s plea to stay Cipla’s cancer clone
Posted: March 1st, 2010, 1:48pm EST
Tags: [edit]
The Supreme Court turned down a request by German drugmaker Bayer AG to stop Mumbai-based Cipla from launching the low-cost version of Bayer’s patented cancer medicine Nexavar while admitting the case. -
Secured lenders insecure over Wockhardt's plan
Posted: March 1st, 2010, 1:30pm EST
Tags: [edit]
Secured and unsecured creditors of debt-ridden pharma firm Wockhardt are singing in different tunes to support the sale of the company’s nutrition business to Abbott Laboratories. -
No interim stay on Cipla’s Nexavar clone
Posted: February 28th, 2010, 2:45pm EST
Tags: [edit]
The Supreme Court turned down a request by German drugmaker Bayer AG to stop Mumbai-based Cipla from launching the low-cost version of Bayer’s patented cancer medicine Nexavar while admitting the case. -
Union Budget 2010: Pharma industry welcomes tax incentives for R&D
Posted: February 26th, 2010, 10:21am EST
Tags: [edit]
Finance minister proposed a weighted tax deduction on expenditure incurred in in-house research and development activities to 200 per cent from the current 150 per cent in the Budget.